Oncotarget Goes Beyond Oncology

Oncotarget is simply a traditional multidisciplinary journal that offers free access. It publishes the papers online on a weekly basis, and each issue or paper is printable on special demand. The name of the online journal means all the molecules, pathways, as well as the cellular functions that are common in both aging and cancer. It also encompasses neurodegeneration, atherosclerosis, neurons, lymphocytes, microbes and cancer cells.

Under the leadership of well-known scientists, Oncotarget offers an incredible platform to the scientists or researchers who contribute to the developments in the world of science. The ultimate goal of the online journal is to bring about a life where the population knows no disease. Oncotarget’s mission includes:

To ensure that scientific results are available, not only rapidly, but also far and wide

To optimize the impact of research through insightful review

To permit the quick sharing of extraordinary discoveries

To remove the existing border between different specialties

To create a connection between the various fields of biomedical science

To nurture the application of both basic and clinical science in the fight against diseases

The recent success that Oncotarget has witnessed has triggered the launch of sections that are beyond oncology. The online journal is now publishing papers in fields such as Neuroscience, Metabolism, Cardiology, Pharmacology, and Cell Biology among many others. The Journal’s rising popularity is largely attributed to the presence of a constructive, punctual, insightful, and multiple peer review, that has helped, and is still helping the authors to boost the impact of their research. Oncotarget is published by Impact Journals

The members of the editorial board namely Carlo M. Croce (previously served as the Cancer of Research’s Editor-in-chief), and the Nobel Prize Winner, Andrew Schally, have published 27 and ten papers respectively, in Oncotarget. During the last four years, four members of Oncotarget have won the highest prize ever – Breakthrough Prize. They include Michael N. Hall, Bert Vogelstein, Stephen J. Elledge, and Alexander Varshavsky.

Oncotarget is the sponsor Gordon Research Conferences – a unique type of scientific conferences that are organized by the members of the community. These conferences emphasize the importance of new results and are normally structured in a manner that allows enough time for meaningful interactions, devoid of distractions. Oncotarget is also available on Dove Press.


Comments are closed, but trackbacks and pingbacks are open.